Furthermore, exosome RNPs showed solid therapeutic potential in acute liver injury, chronic liver fibrosis, and hepatocellular carcinoma mouse models by targeting PUMA, CcnE1, and KAT5, respectively. Here, BBC3 is linked to hepatocellular carcinoma.